Glycosynth is developing an exciting range of new chromogenic substrates in conjunction with Prof John Perry, Microbiology Department, Freeman Hospital, Newcastle upon Tyne, England. These products show a number of distinct advantages over conventional substrates under certain circumstances, and are sure to find important applications.
This section is further divided into the following sub-sections ...
|Chromogenic Catechol substrates|
|Chromogenic β-D-Ribofuranoside substrates|
|Chromogenic Glucuronide substrates|